vimarsana.com
Home
Live Updates
Cingulate : Announces Successful Transfer of CTx-1301 (dexme
Cingulate : Announces Successful Transfer of CTx-1301 (dexme
Cingulate : Announces Successful Transfer of CTx-1301 (dexmethylphenidate) - Form 8-K
Cingulate Announces Successful Transfer of CTx-1301
Proprietary PTR™ Manufacturing Processes to Societal CDMO
Scalable Supply of CTx-1301 Ready to be... | May 3, 2023
Related Keywords
Georgia ,
United States ,
Kansas City ,
Kansas ,
San Diego ,
California ,
David Enloe ,
Shanej Schaffer ,
Matt Kreps ,
Melyssa Weible ,
Thomas Dalton ,
Exchange Commission ,
Platform Technology ,
Securities Exchange ,
Elixir Health Public Relations ,
Trial Program ,
Societal Cdmo Inc ,
Science To Society ,
Master Services Agreement ,
Company Phase ,
Cingulate Inc ,
Darrow Associates ,
Nasdaq ,
Cingulateannounces Successful Transfer ,
Manufacturing Processes ,
Meet Previously Announced Clinical Timelines ,
Precision Timed Release ,
New Drug Application ,
Hyperactivity Disorder ,
Erosion Barrier Layer ,
Investigational New Drug ,
Bringing Science ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Public Relations ,
Cingulate Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Cingulate ,
Nnounces ,
Uccessful ,
Transfer ,
F ,
Roprietary ,
Manufacturing ,
Processes ,
O ,
Societal ,
Scalable ,
Supply ,
Ready ,
O Cing Us17248w1053 ,